|
Volumn 21, Issue 1, 2006, Pages 11-20
|
An open-label extension trial of risperidone monotherapy in the treatment of bipolar I disorder
c
IQVIA
(United States)
|
Author keywords
Bipolar disorder; Extension; Monotherapy; Open label; Risperidone
|
Indexed keywords
PLACEBO;
RISPERIDONE;
ADULT;
AGITATION;
ARTICLE;
BIPOLAR I DISORDER;
BODY WEIGHT;
CENTRAL NERVOUS SYSTEM DISEASE;
CLINICAL GLOBAL IMPRESSION SCALE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DEPRESSION;
DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS;
DISEASE SEVERITY;
DOUBLE BLIND PROCEDURE;
DRUG EFFECT;
DRUG EFFICACY;
DRUG INDUCED HEADACHE;
DRUG TOLERABILITY;
EXTRAPYRAMIDAL SYMPTOM;
EXTRAPYRAMIDAL SYNDROME;
FEMALE;
HUMAN;
HYPERKINESIA;
INSOMNIA;
LABORATORY TEST;
MAJOR CLINICAL STUDY;
MALE;
MANIA;
MONTGOMERY ASBERG DEPRESSION RATING SCALE;
MULTICENTER STUDY;
PERIPHERAL NEUROPATHY;
POSITIVE AND NEGATIVE SYNDROME SCALE;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
RATING SCALE;
RESPIRATORY TRACT DISEASE;
RISK ASSESSMENT;
SCORING SYSTEM;
SIDE EFFECT;
SOMNOLENCE;
STATISTICAL SIGNIFICANCE;
TREATMENT OUTCOME;
TREMOR;
UPPER RESPIRATORY TRACT INFECTION;
ADULT;
ANTIPSYCHOTIC AGENTS;
BIPOLAR DISORDER;
DOUBLE-BLIND METHOD;
FEMALE;
HUMANS;
MALE;
MIDDLE AGED;
PSYCHIATRIC STATUS RATING SCALES;
RISPERIDONE;
SEVERITY OF ILLNESS INDEX;
TIME FACTORS;
|
EID: 31744446774
PISSN: 02681315
EISSN: None
Source Type: Journal
DOI: 10.1097/01.yic.0000177017.41558.fc Document Type: Article |
Times cited : (11)
|
References (5)
|